A total of 18,273 patients receiving angioplasty in hospitals with or without central vascular surgery were followed for 9 months and the costs were evaluated. Mortality and the occurrence of events were not different between the two groups. The cost of treatment was lower in the central vascular surgery centers (23,961 USD versus 25,540 USD,<a href="https://solaci.org/en/2015/06/24/cport-e-comparison-of-percutaneous-treatment-cost-in-hospitals-with-and-without-central-vascular-surgery/" title="Read more" >...</a>

FFR is the gold standard (Dr. William Fearon) Dr. William reported on the benefits of using FFR:&nbsp; &bull; A high degree of accuracy in identifying lesions that cause ischemia. &bull; It allows you to specify angioplasty safely. &bull; It improves results when compared to standard practice. &bull; It is technically safe, easy to perform, economical<a href="https://solaci.org/en/2015/06/24/tct-session-an-assessment-of-the-severity-of-lesions-a-debate-about-the-different-methods-to-assess-coronary-physiology/" title="Read more" >...</a>

The aim of this study was to determine whether patients without ST-segment elevation acute coronary syndromes who were not taking statins previously, can receive high doses of rosuvastatin before coronary angiography or angioplasty and if this action could exert protection in renal function and reduce the incidence of contrast-induced nephropathy (CIN). This prospective study randomized<a href="https://solaci.org/en/2015/06/24/prato-acs-rosuvastatin-reduces-the-incidence-of-contrast-nephropathy-in-patients-with-acute-coronary-syndrome-who-receive-early-invasive-strategy/" title="Read more" >...</a>

Angioplasty of the unprotected distal left main coronary artery with 2 stents presents the less favorable results in the segment. The double kissing (DK) technique and Culotte technique have been reported as effective for the treatment of bifurcation lesions, however this has never been tested for left main coronary artery.&nbsp; The DKCRUSH-III study investigated the<a href="https://solaci.org/en/2015/06/24/dkcrush-iii-crushing-versus-culotte-technique-for-left-main-coronary-artery/" title="Read more" >...</a>

Routine manual vacuum in patients with acute coronary syndrome and ST-segment elevation improves myocardial perfusion according to non-invasive parameters. Invasive assessment of microcirculation has not been adequately studied in this group of patients. The objective of this study was to compare the effect of manual thromboaspiration in perfusion according to the microcirculation resistance index (MRI).<a href="https://solaci.org/en/2015/06/24/pata-stemi-thromboaspiration-correlates-with-a-lower-index-of-microcirculatory-resistance/" title="Read more" >...</a>

The objective of this study was to evaluate whether routine use of FFR in all the coronary arteries could change the strategy in stable patients that underwent angiography for the investigation of a chest pain. We included 200 patients with chest pain; for 72 of them, the strategy would be to provide medical treatment by<a href="https://solaci.org/en/2015/06/24/ripcord-study-ffr-changes-clinical-consideration-of-chest-pain/" title="Read more" >...</a>

There is little information in the literature about the obstruction of the coronary ostia after percutaneous aortic valve implantation. 81 TAVI sites and programs and 6688 patients in total provided information on this complication. Of all, 28 patients (0.66%) developed this complication, being more frequent for balloon-expandable prosthesis and when procedures were performed &#8220;valve in<a href="https://solaci.org/en/2015/06/24/coronary-obstruction-registry-after-tavi/" title="Read more" >...</a>

Bio-absorbable devices are considered safe and effective for stable patients but there is still little information regarding their use in acute patients. ACS POLAR Register (POLishAbsorb Registry for ACS Patients) is a multicenter study which included 88 patients undergoing acute coronary syndrome without ST elevation who received a bio-absorbable platform. The aim of the study<a href="https://solaci.org/en/2015/06/24/polar-acs-bio-absorbable-platform-in-acute-coronary-syndromes/" title="Read more" >...</a>

Absorbable bioplatforms are considered safe and effective in stable patients but their use in the context of acute myocardial infarction with ST segment elevation has not been reported. Low risk of heart attack with low Killip classification could be the stage for this device. 87 consecutive patients experiencing myocardial infarction with ST elevation underwent primary<a href="https://solaci.org/en/2015/06/24/prague-19-bioabsorbable-platform-for-patients-with-st-segment-elevation/" title="Read more" >...</a>